Zenas BioPharma
ZBIO
NASDAQ
IPO2024
about ZBIO
Zenas BioPharma is a biopharmaceutical company focused on developing innovative treatments for rare diseases and oncology through cutting-edge technologies such as gene editing, with a mission to address significant unmet medical needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $15.75 | $16.14 | $13.74 | $891.61M | 3.14M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$1.22 | n/a | n/a | 0% | 0% | 0.05% |